<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RYZB
RayzeBio
$
()


  • Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim

    3/19/2024 - 12:55pm
  • option delistings on March 19th

    3/19/2024 - 08:30am
  • Bristol Myers completes acquisition of RayzeBio

    2/26/2024 - 09:17am
  • Bristol Myers announces expiration of tender offer for RayzeBio

    2/23/2024 - 07:05am
  • The biopharmaceuticals stocks to own in 2024, according to BofA

    1/3/2024 - 10:47am
  • Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited

    1/3/2024 - 06:12am
  • RayzeBio just downgraded at JPMorgan, here's why

    12/28/2023 - 04:52am
  • RayzeBio downgraded to Hold from Buy at Truist

    12/27/2023 - 14:18pm
  • Gracell downgrade, Fusion upgrade: Wall Street's top analyst calls

    12/27/2023 - 11:02am
  • Recent M&A activity bodes well for Fusion Pharmaceuticals, says Oppenheimer

    12/27/2023 - 08:27am
  • Fusion Pharmaceuticals upgraded at Raymond James amid radiopharma M&A

    12/27/2023 - 08:21am
  • RayzeBio deal another 'incremental positive' for Bristol, says Morgan Stanley

    12/27/2023 - 07:59am
  • Cantor says Bristol joins 'radiopharmaceuticals race' with RayzeBio deal

    12/27/2023 - 07:11am
  • Bristol Myers price target lowered by $4 at BofA, here's why

    12/27/2023 - 05:43am
  • What You Missed On Wall Street On Tuesday

    12/26/2023 - 16:32pm
dynamic_feed Breaking News